Correlation Between Aerovate Therapeutics and 25278XAT6

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and 25278XAT6 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and 25278XAT6 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and FANG 425 15 MAR 52, you can compare the effects of market volatilities on Aerovate Therapeutics and 25278XAT6 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of 25278XAT6. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and 25278XAT6.

Diversification Opportunities for Aerovate Therapeutics and 25278XAT6

0.06

Correlation Coefficient

Aerovate Therapeutics  25278XAT6

Significant diversification

The 3 months correlation between Aerovate and 25278XAT6 is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and FANG 425 15 MAR 52 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FANG 425 15 and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with 25278XAT6. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FANG 425 15 has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and 25278XAT6 go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and 25278XAT6

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 3.39 times more return on investment than 25278XAT6. However, Aerovate Therapeutics is 3.39 times more volatile than FANG 425 15 MAR 52. It trades about 0.07 of its potential returns per unit of risk. FANG 425 15 MAR 52 is currently generating about -0.1 per unit of risk. If you would invest  194.00  in Aerovate Therapeutics on December 4, 2024 and sell it today you would earn a total of  46.00  from holding Aerovate Therapeutics or generate 23.71% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	95.08%
Values	Daily Returns

Aerovate Therapeutics  vs.  FANG 425 15 MAR 52

Aerovate Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aerovate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Aerovate Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

FANG 425 15

Risk-Adjusted Performance

Very Weak

Over the last 90 days FANG 425 15 MAR 52 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 25278XAT6 is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Aerovate Therapeutics and 25278XAT6

The main advantage of trading using opposite Aerovate Therapeutics and 25278XAT6 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, 25278XAT6 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 25278XAT6 will offset losses from the drop in 25278XAT6's long position.

The idea behind Aerovate Therapeutics and FANG 425 15 MAR 52 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.